InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-71.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Wallace Peggy, Director. Director active across 1 company, notably Cognition Therapeutics INC. In total, 7 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €46k. Activity tracked since 13 October 2021. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
25,000 sharesCommon StockSEC:0001104659-26-076472:0
34,000 shares0Common StockSEC:0001062993-25-012081:0
8,500 shares0Common StockSEC:0001062993-24-012414:0
6,000 shares0Common StockSEC:0001062993-23-013440:0
12,500 shares@ US$1.2019.0% of flowCommon StockSEC:0001062993-22-022242:0
Ideal exit: 12 Aug 2023 (T+270)
22,461 shares0Common StockSEC:0001062993-22-020049:0
3,000 shares@ US$12.000.026% mcap50.0% of flowCommon StockSEC:0001882178-21-000036:0
Ideal exit: 10 Jul 2022 (T+270)
7 of 7 declarations
About Wallace Peggy
Peggy Wallace is a Director at Cognition Therapeutics Inc. She participates in the strategic decisions and governance of the company, bringing her experience in the biotechnology sector. Her role is important in supporting the innovation and growth of the company.
